Praxis Precision Medicines Reports Q2 2026 Financial Results

What Happened

• On August 6, 2026, Praxis Precision Medicines announced its financial results for the quarter ended June 30, 2026. The company furnished a press release with those announcements as Exhibit 99.1 to its Form 8-K.
• On the same date Praxis updated its corporate presentation for investor and analyst meetings; that presentation is available on the company’s “Investors + Media” website page and was furnished as Exhibit 99.2.

Key Details

• Filing date: August 6, 2026 (Form 8-K).
• Reporting period: quarter ended June 30, 2026.
• Exhibits: Press release (Exhibit 99.1) and August 2026 corporate presentation (Exhibit 99.2) furnished with the 8-K.
• Disclosure note: The information and exhibits were furnished (not “filed”), so they are not subject to Section 18 liability or automatically incorporated by reference into other filings.

Why It Matters

• This 8-K provides the company’s most recent quarterly results and an updated investor presentation—key sources for shareholders tracking Praxis’s earnings, revenue trends, and corporate updates.
• Investors should review the furnished press release and presentation (available on the company website or via the SEC filing) for the specific financial figures, guidance (if any), and pipeline or strategic details that could affect the stock.